Fischer Leah S, Asher Alice, Stein Renee, Becasen Jeffrey, Doreson Amanda, Mermin Jonathan, Meltzer Martin I, Edlin Brian R
National Center for Emerging and Zoonotic Infectious Diseases, Atlanta, GA, United States of America.
National Center for HIV/AIDS, STD and TB Prevention, Viral Hepatitis, Atlanta, GA, United States of America.
BMC Public Health. 2025 Mar 25;25(1):1135. doi: 10.1186/s12889-025-22210-8.
It is estimated that over 111,000 people in the U.S. died from a drug overdose in the twelve-month period ending in July 2023. More than three-quarters of those deaths were attributed to opioids. Naloxone has long been available in healthcare facilities to reverse opioid overdose rapidly and safely but is not universally accessible for use in community settings where overdoses occur. We conducted a systematic literature review and meta-analysis to assess the effectiveness of overdose education and naloxone distribution (OEND) programs in three types of community settings to reduce overdose deaths among people who use opioids nonmedically.
We systematically searched electronic databases, including Medline (OVID), Embase (OVID), Psycinfo (OVID), and Global Health (OVID), for peer-reviewed studies of OEND programs published during 2003-2018 (Group 1) that reported overdose outcomes individual level survivals or deaths immediately following naloxone administration. The PRISMA checklist guided screening, quality assessment, and data abstraction. We later identified studies published during 2018-2022 (Group 2), when drug usage and fentanyl-related overdose deaths notably increased, differed from earlier ones. We conducted meta-analyses on both Groups using random effects models to estimate summary survival proportions.
Among the 44 Group 1 studies published during 2003-2018, survival did not differ by time (year), location, naloxone dose, or route of administration, but studies of OEND programs serving people who use drugs reported 98.3% (95% CI: 97.5-98.8) survival; those serving family of people who use drugs or other community members reported 95.0% (95% CI: 91.4-97.1) survival; and those for police reported 92.4% (95% CI: 88.9-94.8) survival (p < 0.01). Five Group 2 studies (2018-2022) yielded similar results.
Community-based naloxone distribution programs can be effective in preventing opioid overdose deaths. The paper demonstrates that in the face of increasing overdose deaths over time, survival after naloxone administration has been sustained. The very high survival rates provide clear evidence for public health to continue efforts to expand channels for naloxone distribution in community settings.
据估计,在截至2023年7月的12个月期间,美国有超过11.1万人死于药物过量。其中超过四分之三的死亡归因于阿片类药物。纳洛酮长期以来在医疗机构中可用,可迅速、安全地逆转阿片类药物过量,但在过量用药发生的社区环境中并非普遍可及。我们进行了一项系统的文献综述和荟萃分析,以评估过量用药教育和纳洛酮分发(OEND)项目在三种社区环境中对减少非医疗使用阿片类药物人群过量用药死亡的有效性。
我们系统地检索了电子数据库,包括Medline(OVID)、Embase(OVID)、Psycinfo(OVID)和Global Health(OVID),以查找2003年至2018年期间发表的关于OEND项目的同行评审研究(第1组),这些研究报告了纳洛酮给药后个体层面的过量用药结果(存活或死亡)。PRISMA清单指导筛选、质量评估和数据提取。我们随后确定了2018年至2022年期间发表的研究(第2组),当时药物使用和与芬太尼相关的过量用药死亡显著增加,与早期研究不同。我们对两组研究都使用随机效应模型进行荟萃分析,以估计总体存活比例。
在2003年至2018年期间发表的44项第1组研究中,存活情况在时间(年份)、地点、纳洛酮剂量或给药途径方面没有差异,但为使用药物人群提供服务的OEND项目研究报告的存活率为98.3%(95%CI:97.5 - 98.8);为使用药物人群的家属或其他社区成员提供服务的研究报告的存活率为95.0%(95%CI:91.4 - 97.1);为警察提供服务的研究报告的存活率为92.4%(95%CI:88.9 - 94.8)(p < 0.01)。五项第2组研究(2018 - 2022年)得出了类似的结果。
基于社区的纳洛酮分发项目在预防阿片类药物过量死亡方面可能是有效的。该论文表明,随着时间的推移,面对过量用药死亡人数的增加,纳洛酮给药后的存活率一直保持。非常高的存活率为公共卫生继续努力扩大社区环境中纳洛酮分发渠道提供了明确证据。